Cargando…
Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis)
In India an estimated 0.8% of the population is suffering from Psoriasis. It is a papulo-squamous disorder of the skin, characterized by sharply defined erythemato-squamous lesions. It is chronic and is well known for its course of remissions and exacerbations. The exact etiology is still unknown. T...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611636/ https://www.ncbi.nlm.nih.gov/pubmed/23559794 http://dx.doi.org/10.4103/0974-8520.105242 |
_version_ | 1782264552124055552 |
---|---|
author | Mangal, Gunjan Mangal, Gopesh Sharma, Radhey Shyam |
author_facet | Mangal, Gunjan Mangal, Gopesh Sharma, Radhey Shyam |
author_sort | Mangal, Gunjan |
collection | PubMed |
description | In India an estimated 0.8% of the population is suffering from Psoriasis. It is a papulo-squamous disorder of the skin, characterized by sharply defined erythemato-squamous lesions. It is chronic and is well known for its course of remissions and exacerbations. The exact etiology is still unknown. This condition is comparable with Mandala Kushtha in Ayurvedic system of medicine. Shodhana procedures are reliable to control the disease. Forty patients, fulfilling the inclusion criteria, were selected and randomly divided into four groups with 10 patients in each group. In Group A, Vamana and Virechana was administered once during the trial period. In Group B, Vamana and Virechana followed by Dermo-care in the dose of 5 g twice a day for the period of 2 months. In Group C, only Dermo-care was administered. In Group D, Tab. Neotrexate (Methotrexate) 7.5 mg/week was given under the supervision of dermatologist. Marked improvement was observed in 10% of the patients in Group B. Moderate improvement was observed in 20% of the patients in Group A, 90% in Group B, and 80% in Group D. Mild improvement was observed in 80% of the patients in Group A, 100% in Group C, and 20% in Group D. |
format | Online Article Text |
id | pubmed-3611636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36116362013-04-04 Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) Mangal, Gunjan Mangal, Gopesh Sharma, Radhey Shyam Ayu Clinical Research In India an estimated 0.8% of the population is suffering from Psoriasis. It is a papulo-squamous disorder of the skin, characterized by sharply defined erythemato-squamous lesions. It is chronic and is well known for its course of remissions and exacerbations. The exact etiology is still unknown. This condition is comparable with Mandala Kushtha in Ayurvedic system of medicine. Shodhana procedures are reliable to control the disease. Forty patients, fulfilling the inclusion criteria, were selected and randomly divided into four groups with 10 patients in each group. In Group A, Vamana and Virechana was administered once during the trial period. In Group B, Vamana and Virechana followed by Dermo-care in the dose of 5 g twice a day for the period of 2 months. In Group C, only Dermo-care was administered. In Group D, Tab. Neotrexate (Methotrexate) 7.5 mg/week was given under the supervision of dermatologist. Marked improvement was observed in 10% of the patients in Group B. Moderate improvement was observed in 20% of the patients in Group A, 90% in Group B, and 80% in Group D. Mild improvement was observed in 80% of the patients in Group A, 100% in Group C, and 20% in Group D. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3611636/ /pubmed/23559794 http://dx.doi.org/10.4103/0974-8520.105242 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Mangal, Gunjan Mangal, Gopesh Sharma, Radhey Shyam Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) |
title | Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) |
title_full | Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) |
title_fullStr | Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) |
title_full_unstemmed | Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) |
title_short | Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) |
title_sort | clinical efficacy of shodhana karma and shamana karma in mandala kushtha (psoriasis) |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611636/ https://www.ncbi.nlm.nih.gov/pubmed/23559794 http://dx.doi.org/10.4103/0974-8520.105242 |
work_keys_str_mv | AT mangalgunjan clinicalefficacyofshodhanakarmaandshamanakarmainmandalakushthapsoriasis AT mangalgopesh clinicalefficacyofshodhanakarmaandshamanakarmainmandalakushthapsoriasis AT sharmaradheyshyam clinicalefficacyofshodhanakarmaandshamanakarmainmandalakushthapsoriasis |